Globe Life Inc. (NYSE:GL – Get Free Report)’s stock price reached a new 52-week high on Thursday . The stock traded as high as $163.50 and last traded at $162.9420, with a volume of 449020 shares traded. The stock had previously closed at $159.33.
Analyst Ratings Changes
Several research firms have weighed in on GL. Piper Sandler boosted their target price on shares of Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 26th. Evercore set a $157.00 target price on shares of Globe Life in a research report on Wednesday, February 18th. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Morgan Stanley boosted their target price on shares of Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, May 21st. Finally, Keefe, Bruyette & Woods restated a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and an average target price of $174.11.
Read Our Latest Report on Globe Life
Globe Life Stock Performance
Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm posted $3.07 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Sell-side analysts forecast that Globe Life Inc. will post 15.62 earnings per share for the current fiscal year.
Globe Life Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.
Insider Activity
In related news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 105,929 shares of company stock valued at $16,382,450. 2.11% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Globe Life
Several large investors have recently made changes to their positions in the company. Parallel Advisors LLC lifted its stake in shares of Globe Life by 6.4% in the 1st quarter. Parallel Advisors LLC now owns 1,756 shares of the company’s stock valued at $244,000 after purchasing an additional 105 shares during the period. Glenmede Trust Co. NA lifted its stake in shares of Globe Life by 5.8% in the 1st quarter. Glenmede Trust Co. NA now owns 7,396 shares of the company’s stock valued at $1,029,000 after purchasing an additional 406 shares during the period. Groupama Asset Managment acquired a new position in shares of Globe Life in the 1st quarter valued at $466,000. Edgestream Partners L.P. acquired a new position in shares of Globe Life in the 1st quarter valued at $7,513,000. Finally, Bull Harbor Capital LLC acquired a new position in shares of Globe Life in the 1st quarter valued at $538,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Further Reading
- Five stocks we like better than Globe Life
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
